Literature DB >> 11018286

Myristoylation-dependent N-terminal cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cellular extracts.

T Braun1, R A McIlhinney, G Vergères.   

Abstract

The myristoylated alanine-rich C kinase substrate (MARCKS) has been proposed to regulate the plasticity of the actin cytoskeleton at its site of attachment to membranes. In macrophages, MARCKS is implicated in various cellular events including motility, adhesion and phagocytosis. In this report we show that macrophage extracts contain a protease which specifically cleaves human MARCKS, expressed in a cell-free system or in E. coli, between Lys-6 and Thr-7. Cleavage of MARCKS decreases its affinity for macrophage membranes by ca. one order of magnitude, highlighting the contribution of the myristoyl moiety of MARCKS to membrane binding. Importantly, cleavage requires myristoylation of MARCKS. Furthermore, MARCKS-related protein (MRP), the second member of the MARCKS family, is not digested. Since Thr-7 is lacking in MRP this suggests that Thr-7 at the P1 position is important for the recognition of lipid-modified substrates. A different product is observed when MARCKS is incubated with a calf brain cytosolic extract. This product can be remyristoylated in the presence of myristoyl-CoA and N-myristoyl transferase, demonstrating that cycles of myristoylation/demyristoylation of MARCKS can be achieved in vitro. Although the physiological relevance of these enzymes still needs to be demonstrated, our results reveal the presence of a new class of cleaving enzymes recognizing lipid-modified protein substrates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018286     DOI: 10.1016/s0300-9084(00)01154-8

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  11 in total

Review 1.  Cross-talk unfolded: MARCKS proteins.

Authors:  Anna Arbuzova; Arndt A P Schmitz; Guy Vergères
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Calpain and MARCKS protein regulation of airway mucin secretion.

Authors:  W Randall Lampe; Joungjoa Park; Shijing Fang; Anne L Crews; Kenneth B Adler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-16       Impact factor: 3.410

Review 3.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

4.  Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage.

Authors:  Sandrine Dulong; Sebastien Goudenege; Karine Vuillier-Devillers; Stéphane Manenti; Sylvie Poussard; Patrick Cottin
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

5.  Protein myristoylation in health and disease.

Authors:  Megan H Wright; William P Heal; David J Mann; Edward W Tate
Journal:  J Chem Biol       Date:  2009-11-07

Review 6.  Myristoylation: An Important Protein Modification in the Immune Response.

Authors:  Daniel Ikenna Udenwobele; Ruey-Chyi Su; Sara V Good; Terry Blake Ball; Shailly Varma Shrivastav; Anuraag Shrivastav
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 7.  Protein N-myristoylation: functions and mechanisms in control of innate immunity.

Authors:  Bin Wang; Tong Dai; Wenhuan Sun; Yujun Wei; Jiang Ren; Long Zhang; Mengdi Zhang; Fangfang Zhou
Journal:  Cell Mol Immunol       Date:  2021-03-17       Impact factor: 11.530

8.  Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein.

Authors:  Laura E Ott; Eui Jae Sung; Adam T Melvin; Mary K Sheats; Jason M Haugh; Kenneth B Adler; Samuel L Jones
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

Review 9.  N-myristoylation: from cell biology to translational medicine.

Authors:  Meng Yuan; Zi-Han Song; Mei-Dan Ying; Hong Zhu; Qiao-Jun He; Bo Yang; Ji Cao
Journal:  Acta Pharmacol Sin       Date:  2020-03-18       Impact factor: 6.150

10.  Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.

Authors:  Joni V Lindbohm; Nina Mars; Keenan A Walker; Archana Singh-Manoux; Gill Livingston; Eric J Brunner; Pyry N Sipilä; Kalle Saksela; Jane E Ferrie; Ruth C Lovering; Stephen A Williams; Aroon D Hingorani; Rebecca F Gottesman; Henrik Zetterberg; Mika Kivimäki
Journal:  Alzheimers Dement       Date:  2021-08-02       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.